A
29.91
0.04 (0.13%)
Penutupan Terdahulu | 29.87 |
Buka | 29.81 |
Jumlah Dagangan | 330,592 |
Purata Dagangan (3B) | 1,563,627 |
Modal Pasaran | 3,604,753,152 |
Harga / Jualan (P/S) | 459.11 |
Harga / Buku (P/B) | 3.04 |
Julat 52 Minggu | |
Tarikh Pendapatan | 7 Aug 2025 - 11 Aug 2025 |
Margin Operasi (TTM) | -8,360.90% |
EPS Cair (TTM) | -3.00 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -55.60% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 0.45% |
Nisbah Semasa (MRQ) | 16.91 |
Aliran Tunai Operasi (OCF TTM) | -355.32 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -245.73 M |
Pulangan Atas Aset (ROA TTM) | -22.47% |
Pulangan Atas Ekuiti (ROE TTM) | -34.19% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Biotechnology (US) | Bercampur | Menurun |
Biotechnology (Global) | Bercampur | Menurun | |
Stok | Avidity Biosciences, Inc. | Menurun | Menurun |
AISkor Stockmoo
2.9
Konsensus Penganalisis | 4.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 2.0 |
Purata Bergerak Teknikal | 3.5 |
Osilator Teknikal | 2.0 |
Purata | 2.88 |
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD. |
|
Sektor | Healthcare |
Industri | Biotechnology |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 5.17% |
% Dimiliki oleh Institusi | 112.41% |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 96.00 (Cantor Fitzgerald, 220.96%) | Beli |
Median | 65.00 (117.32%) | |
Rendah | 54.00 (B of A Securities, 80.54%) | Beli |
Purata | 66.89 (123.64%) | |
Jumlah | 9 Beli | |
Harga Purata @ Panggilan | 31.53 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Goldman Sachs | 10 Jul 2025 | 55.00 (83.88%) | Beli | 31.47 |
Cantor Fitzgerald | 27 Jun 2025 | 96.00 (220.96%) | Beli | 29.03 |
Wolfe Research | 17 Jun 2025 | 55.00 (83.88%) | Beli | 29.36 |
Raymond James | 11 Jun 2025 | 65.00 (117.32%) | Beli | 32.01 |
Barclays | 10 Jun 2025 | 59.00 (97.26%) | Beli | 33.62 |
Citigroup | 10 Jun 2025 | 75.00 (150.75%) | Beli | 33.62 |
B of A Securities | 09 Jun 2025 | 54.00 (80.54%) | Beli | 32.66 |
Chardan Capital | 09 Jun 2025 | 75.00 (150.75%) | Beli | 32.66 |
09 May 2025 | 65.00 (117.32%) | Beli | 27.87 | |
HC Wainwright & Co. | 12 May 2025 | 68.00 (127.35%) | Beli | 29.33 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |